Publication
Title
The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment
Author
Abstract
Therapeutic drug monitoring generally focuses on the plasma compartment only. Differentiation between the total plasma concentration and the free fraction (plasma water) has been described for a number of limited drugs. Besides the plasma compartment, blood has also a cellular fraction which has by far the largest theoretical surface and volume for drug transport. It is with anti-cancer drugs that major progress has been made in the study of partition between the largest cellular blood compartment, i.e., erythrocytes, and the plasma compartment. The aim of the present review is to detail the progress made in predicting what a drug does in the body, i.e., pharmacodynamics including toxicity and plasma and/or red blood cell concentration monitoring. Furthermore, techniques generally used in anti-cancer drug monitoring are highlighted. Data for complex Bayesian statistical approaches and population kinetics studies are beyond the scope of this review, since this is generally limited to the plasma compartment only.
Language
English
Source (journal)
Clinical chemistry and laboratory medicine. - Berlin, 1998, currens
Publication
Berlin : 2004
ISSN
1434-6621 [print]
1437-4331 [online]
DOI
10.1515/CCLM.2004.244
Volume/pages
42 :11 (2004) , p. 1219-1227
ISI
000225438100004
Full text (Publisher's DOI)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 03.01.2013
Last edited 29.12.2021
To cite this reference